Works matching DE "MONOCLONAL antibodies"

Results: 5000
    1

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Anti-pyroglutamate-3 Aβ immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Aβ amyloidosis.

    Published in:
    Acta Neuropathologica, 2025, v. 149, n. 1, p. 1, doi. 10.1007/s00401-025-02892-5
    By:
    • Liao, Fan;
    • Calvo-Rodriguez, Maria;
    • Chhaya, Meha;
    • Sefrin, Julian P;
    • Charych, Erik I;
    • Mezler, Mario;
    • Clausznitzer, Diana;
    • McGlame, Emily J;
    • Zhao, Karen;
    • Rodgers, Allison;
    • Cao, Yang;
    • Secker, Philipp F;
    • Fernandez Garcia-Agudo, Laura;
    • Huang, Lili;
    • Klein, Corinna;
    • Dellovade, Tammy;
    • Karran, Eric
    Publication type:
    Article
    13
    14
    15

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    16
    17

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    A Case of Localised Immediate Hypersensitivity Reaction to Bimekizumab.

    Published in:
    Contact Dermatitis (01051873), 2025, v. 92, n. 6, p. 488, doi. 10.1111/cod.14774
    By:
    • Lasheras‐Pérez, Miguel Antonio;
    • López‐Salgueiro, Ramón;
    • Palacios‐Diaz, Rodolfo David;
    • Pujol‐Marco, Conrad;
    • Botella‐Estrada, Rafael;
    • Ibañez‐Echevarría, Ethel
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Targeting CD38 in Antibody-Mediated Rejection.

    Published in:
    Transplant International, 2025, p. 1, doi. 10.3389/ti.2025.14343
    By:
    • Mayer, Katharina A.;
    • Budde, Klemens;
    • Diebold, Matthias;
    • Halloran, Philip F.;
    • Böhmig, Georg A.
    Publication type:
    Article
    36
    37
    38
    39

    Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1727, doi. 10.3390/cancers17101727
    By:
    • Lim, Annette M.;
    • Baker, Benjamin;
    • Lion, Peter;
    • Angel, Christopher M.;
    • Simmons, Jennifer;
    • Jackson, Bryce;
    • Magarey, Matthew;
    • Webb, Angela;
    • Nguyen, Kevin;
    • Hudson, Jo;
    • Chin, Kwang Yang;
    • Cardin, Anthony;
    • Ravi, Rajeev;
    • Morrison, Edwin;
    • Quinn, Tam;
    • Hunt, Ian;
    • Rischin, Danny
    Publication type:
    Article
    40
    41
    42

    Identification and characterization of a target antigen recognized by the monoclonal antibody against Opisthorchis viverrini.

    Published in:
    PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0324137
    By:
    • Techasen, Anchalee;
    • Worasith, Chanika;
    • Muengsaen, Duangkamon;
    • Ponglong, Jiraprapa;
    • Mahalapbutr, Panupong;
    • Kongtaworn, Napat;
    • Rungrotmongkol, Thanyada;
    • Khongsukwiwat, Kanoknan;
    • Wongphutorn, Phattharaphon;
    • Wangboon, Chompunoot;
    • Homwonk, Chutima;
    • Chaiyadet, Sujittra;
    • Laha, Thewarach;
    • Suttiprapa, Sutas;
    • Sakonsinsiri, Chadamas;
    • Sithithaworn, Paiboon;
    • Thanan, Raynoo
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50